
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
15-Lipoxygenase promotes resolution of inflammation in lymphedema by controlling Treg cell function through IFN-β
Audrey Zamora, Manon Nougué, L. Verdu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Audrey Zamora, Manon Nougué, L. Verdu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Dynamics of Immune Cell Infiltration and Fibroblast-Derived IL-33/ST2 Axis Induction in a Mouse Model of Post-Surgical Lymphedema
Kazuhisa Uemura, Keiichi Katayama, Toshihiko Nishioka, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1371-1371
Open Access
Kazuhisa Uemura, Keiichi Katayama, Toshihiko Nishioka, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1371-1371
Open Access
Inflammation and cancer: molecular mechanisms and clinical consequences
Hikmet Akkız, Cem Şimşek, Deniz Balcı, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Hikmet Akkız, Cem Şimşek, Deniz Balcı, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
The microenvironment of secondary lymphedema. The key to finding effective treatments?
Lazina Hossain, Karina Pereira Gomes, Samaneh Safarpour, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167677-167677
Open Access
Lazina Hossain, Karina Pereira Gomes, Samaneh Safarpour, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167677-167677
Open Access
Cynaroside: a potential therapeutic agent targeting arachidonate 15-lipoxygenase to mitigate cerebral ischemia/reperfusion injury
Wenpeng Cao, Yufeng Hu, Yu Xia, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Wenpeng Cao, Yufeng Hu, Yu Xia, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Single-nuclear transcriptomics of lymphedema-associated adipose reveals a pro-lymphangiogenic stromal cell population
Gregory P. Westcott, Margo P. Emont, Anton Gulko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Gregory P. Westcott, Margo P. Emont, Anton Gulko, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept)
Natália Cristina Gomes-da-Silva, Isabelle Xavier-de-Britto, Marília Amável Gomes Soares, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 649-649
Open Access
Natália Cristina Gomes-da-Silva, Isabelle Xavier-de-Britto, Marília Amável Gomes Soares, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 649-649
Open Access
Update February 2024
Francine Blei
Lymphatic Research and Biology (2024) Vol. 22, Iss. 1, pp. 66-88
Closed Access
Francine Blei
Lymphatic Research and Biology (2024) Vol. 22, Iss. 1, pp. 66-88
Closed Access
Isoniazid Derivatives as Potential Lipoxygenase‐15 Inhibitors: In‐vitro and In‐silico Studies
Mashael A. Alghamdi, Faizul Azam, Md Jamir Anwar, et al.
ChemistrySelect (2024) Vol. 9, Iss. 31
Closed Access
Mashael A. Alghamdi, Faizul Azam, Md Jamir Anwar, et al.
ChemistrySelect (2024) Vol. 9, Iss. 31
Closed Access
Comprehensive time-course gene expression evaluation of high-risk beef cattle to establish immunological characteristics associated with undifferentiated bovine respiratory disease
Matthew A. Scott, Robert Valeris-Chacín, Alexis C. Thompson, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Matthew A. Scott, Robert Valeris-Chacín, Alexis C. Thompson, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Anti-CTLA4 treatment reduces lymphedema risk potentially through a systemic expansion of the FOXP3+ Treg population
Stefan Wolf, Matiar Madanchi, Patrick Turko, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Stefan Wolf, Matiar Madanchi, Patrick Turko, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access